Ads
related to: spielberger test anxiety inventory for children and adolescents taica
Search results
Results From The WOW.Com Content Network
The Test Anxiety Inventory for Children and Adolescent (TAICA) is a way to measure and assess test anxiety in children and adolescents in Grades 4 through 12. Those individuals who are being assessed rate their responses on a 5-point Likert-type scale ranging from 1 (never true about me) to 5 (always true about me).
These include the State-Trait Anger Scale (STAS) and the State-Trait Anger Expression Inventory (STAXI). Alternate forms of the STAI have been developed, including a short-form version (STAI-6) as well as a child form, the State-Trait Anxiety Inventory for Children (STAIC). [citation needed] The STAI requires a sixth grade reading level.
Hamilton Anxiety Scale (HAM-A) [6] [7] Hospital Anxiety and Depression Scale; Panic and Agoraphobia Scale (PAS) Panic Disorder Severity Scale (PDSS) PTSD Symptom Scale – Self-Report Version; Screen for child anxiety related disorders; Social Phobia and Anxiety Inventory-Brief form; Social Phobia Inventory (SPIN) Taylor Manifest Anxiety Scale
Charles Donald Spielberger (March 28, 1927 – June 11, 2013) was an American clinical community psychologist well-known for his development of the State-Trait Anxiety Inventory. [ 1 ] In 1972, as incoming president of the Southeastern Psychological Association he appointed the organization's Task Force on the Status of Women, chaired by Ellen ...
The Child and Adolescent Symptom Inventory (CASI) is a behavioral rating checklist created by Kenneth Gadow and Joyce Sprafkin that evaluates a range of behaviors related to common emotional and behavioral disorders identified in the Diagnostic and Statistical Manual of Mental Disorders (DSM), including attention deficit hyperactivity disorder, oppositional defiant disorder, conduct disorder ...
AUC of .67, able to discriminate between children with anxiety versus non-anxiety disorders in clinical settings, as well as individual types of anxiety disorders. [4] Validity generalization: Good: Used in clinical settings for children and adolescents ages 9–18. Reliable across genders and ethnicities.